FP7Реинтеграция2008–2012

AID AND BEYOND · AID in adaptive immunity and beyond

7РП — „Хора“ (Действия „Мария Кюри“)

Период
2008-12-01 → 2012-11-30
Финансиране от ЕС
100 000 €
Участници
1
Схема
MC-IRG

Линиите свързват координатора с партньорите.

Накратко на български

Ензимът AID променя гените на B-клетките, за да създава по-ефективни антитела срещу инфекции. Разбирането на неговата работа помага да се разбере как се развива имунният отговор и защо понякога възникват генетични мутации, водещи до рак.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

AID in adaptive immunity and beyond

Since its discovery in 1999, activation-induced deaminase (AID) has attracted the attention of immunologists and geneticists. AID is a cytidine deaminase that edits the immunoglobulin genes of activated B cells. During somatic hypermutation, it introduces the point mutations required to generate the diversity that fuels the process of affinity maturation, eventually improving the affinity of the antibodies. During class switch recombination (CSR), it triggers recombination events leading to the replacement of the constant region of the immunoglobulin heavy chain (class switch recombination), thus producing antibodies with different effector functions. In addition to its essential role in adaptive immunity, AID has an oncogenic potential due to the generation of double-strand breaks in the genome that can result in translocations. More recently, the expression of AID in non-lymphoid cells raised a number of new hypotheses concerning its role in the global demethylation of the genome and in meiotic recombination. We have performed complementary approaches to elucidate the role of AID in the germ-line and in CSR, combining clinical results, mice models, genetically engineered molecules and functional assays. Specifically, we have shown that the expression of AID in the germ-line has no impact on the frequency of meiotic recombination, which is a significant contribution for the community working on AID and genome stability. In addition, we have found in females that the AID protein is expressed mainly in the somatic granulosa cells surrounding the oocyte, an observation that raises a number of new hypotheses concerning the role of AID in the protection of the genome of the gametes. On a different front, we have tested AID orthologs from a shark and a sturgeon using functional assays, thus showing that the specific ability of the C-terminus of AID to drive CSR evolved at least 50 million years before the appearance of CSR in Tetrapods (amphibians, reptiles, birds and mammals) and that such function was conserved in independent evolutionary branches for 450 million years. This paradoxical finding suggested that a conserved role of the C-terminus of AID was coopted in the context of CSR and using chimeric molecules we have shown that such role is not only conserved in AID orthologs but shared with the other enzyme that introduces physiologic double-strand breaks in lymphocytes. Future experiments will detail the exact nature of this function, but the available evidence points to the active recruitment of a DNA repair pathway. 1. Trancoso I, Cortesao CS, Zhao Y, Hammarstr?m QP, Barreto VM (in preparation). The RAG1/RAG2 complex and Activation-Induced Cytidine Deaminase converged for the recruitment of the Non-Homologous End Joining repair pathway. 2. Carat?o N, Reis PH, Freitas RF, Cortes?o CS, Jacob CMA, Pastorino AC, Carneiro-Sampaio M, Barreto VM (ready for submission) A Novel Activation-Induced Cytidine Deaminase (AID) Mutation in patients with hyper-IgM type 2 syndrome. 3. Cortes?o SCS, Freitas RF, Barreto VM (submitted) Activation-Induced Cytidine Deaminase does not impact on murine meiotic recombination. 4. Barreto VM and Magor B. (2011) Activation-induced cytidine deaminase structure and functions: A species comparative view. " Developmental & Comparative Immunology. 35 (9): 991-1007. 5. Pavri R, Gazumyan A, Jankovic M, Di Virgilio M, Klein I, Ansarah-Sobrinho C, Resch W, Yamane A, Reina San-Martin B, Barreto VM, Nieland TJ, Root DE, Casellas R, Nussenzweig MC. (2010) Activation-induced cytidine deaminase targets DNA at sites of RNA polymerase II stalling by interaction with Spt5. Cell 143 (1): 122-33

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

This proposal revolves around the enzyme Activation-Induced Deaminase (AID). AID plays a pivotal role in adaptive immunity because it is essential to introduce the lesions in the immunoglobulin genes that ultimately lead to somatic hypermutation (SHM), class switch recombination (CSR) and immunoglobulin gene conversion (Ig GC). However, its mutagenic ability has a pernicious side effect and AID has been implicated in B lymphomas and other neoplasias. Finally, because AID belongs to a family of cytidine deaminases including members with anti-retroviral properties due to their targeting of viral cDNA, cytidine deamination of DNA is yet another unforeseen link between innate and adaptive immunity. Here, I plan to use classical molecular approaches and genetically engineered mice to discover AID co-factors for CSR, to address the rules governing AID targeting to the immunoglobulin loci and to establish murine models to evaluate the impact of ectopic expression of AID. In addition, I describe how a functional assay I developed previously to characterize orthologous AID forms can be adapted to clone molecules from distant species able to introduce lesions in DNA, with the goal of better elucidating the evolution of somatic DNA modification.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз